Kumiko Ui-Tei, Ph.D. Co-Founder
Scientific Advisor・Chief Technology Officer

Project Professor, NucleoTIDE and PepTIDE Drug Discovery Center, Institute of Science Tokyo

Project Researcher, Graduate School of Science, The University of Tokyo
Adjunct Lecturer, Graduate School of Frontier Sciences, The University of Tokyo

Visiting Professor, Tokyo University of Science

The Inventor of SNPD-siRNA which is the key technology of ANRis Inc., and a pioneer in basic RNA science study.
After getting her Ph.D. from Graduate School of Science and Engineering at Waseda University, she started her career as a project researcher at Mitsubishi Kasei Institute of Life Sciences. Before assuming her current position, she was an assistant, a lecturer and an assistant professor at Nippon Medical School, and an associate professor at the Department of Biological Sciences, Graduate School of Science, The University of Tokyo. The Society Award from Nucleic Acids Therapeutics Society of Japan (2019).

Hiroaki Taniguchi, MD, Ph.D. Co-Founder
Scientific Advisor

Professor, Division of Innovative Cancer Control Research, Cancer Research Institute of Kanazawa University

Experience in conducting the first trials of siRNA for both non-clinical and clinical in Japan.
Experience in conducting the first trials of siRNA for both non-clinical and clinical in Japan. After getting his Ph.D. from Graduate School of Medicine, Sapporo Medical University, he started his career at the National Cancer Research Center in Spain. Before assuming his current position, he was a project assistant professor at Sapporo Medical University and a project associate professor at The Institute of Medical Science, The University of Tokyo. The Mizushima Award from The Japan Society of Drug Delivery System (2021)

Yoshimasa Asano, Ph.D.
Scientific Advisor

Assistant Professor, Laboratory of Health Science, School of Pharmacy, Nihon University

Contributed to the invention and validation of SNPD-siRNA which is the key technology of ANRis Inc., majoring in animal physiology.
After getting his Ph.D. from The University of Tokyo, he started his career as an assistant professor at the Department of Biological Sciences, Graduate School of Science, The University of Tokyo before assuming his current position.

Yoshihiko Shiono 
Chief Executive Officer

Experience includes multiple business divestiture negotiations at pharmaceutical companies, demonstrating strong expertise in medical business strategy and development. Graduated from the University of Tokyo (Faculty of Law) and Harvard Business School, he has built a track record primarily in organizational and human resource development at NetLearning, Inc., Sanyo Electric Co., Accenture, and IBM Japan. After serving as an Executive Officer for sales promotion and business strategy at Ayumi Pharmaceutical Holdings Co., Ltd., he assumed his current position. He has extensive experience in organizational and talent transformation, as well as in business strategy, distribution, and sales promotion within the pharmaceutical industry. 

Kazuya Kawahara Co-Founder
Board Member

Strength in business development with his wide network and knowledge of genome information.
He also has experience in commercializing a genome sequence design tool (siDirect) developed by Associate Professor Ui-Tei at The University of Tokyo and other business experience in the field of genome information. He graduated from The University of Electro-Communications, worked at several IT companies and founded Retriva, Inc., spin-out from Preferred Infrastructure, Inc. Director of Retriva, Inc.